Scheuerer S[au] - Search Results

Year	Number of Results
1996	1
1998	2
2001	2
2005	1
2009	1
2010	1
2011	2
2017	2
2018	1
2019	1
2021	1
2023	0

1

Computational approaches to predict drug metabolism.

Czodrowski P, Kriegl JM, Scheuerer S, Fox T. Czodrowski P, et al. Among authors: scheuerer s. Expert Opin Drug Metab Toxicol. 2009 Jan;5(1):15-27. doi: 10.1517/17425250802568009. Expert Opin Drug Metab Toxicol. 2009. PMID: 19236226 Review.

2

An Integrative Approach for Improved Assessment of Cardiovascular Safety Data.

Wallman M, Scheuerer S, Martel E, Pairet N, Jirstrand M, Gabrielsson J. Wallman M, et al. Among authors: scheuerer s. J Pharmacol Exp Ther. 2021 May;377(2):218-231. doi: 10.1124/jpet.120.000348. Epub 2021 Mar 1. J Pharmacol Exp Ther. 2021. PMID: 33648939

3

Modeling energy intake and body weight effects of a long-acting amylin analogue.

Brings A, Borghardt JM, Skarbaliene J, Baader-Pagler T, Deryabina MA, Rist W, Scheuerer S. Brings A, et al. Among authors: scheuerer s. J Pharmacokinet Pharmacodyn. 2018 Apr;45(2):215-233. doi: 10.1007/s10928-017-9557-6. Epub 2017 Nov 23. J Pharmacokinet Pharmacodyn. 2018. PMID: 29170989

4

pH-dependent solubility and permeability profiles: A useful tool for prediction of oral bioavailability.

Sieger P, Cui Y, Scheuerer S. Sieger P, et al. Among authors: scheuerer s. Eur J Pharm Sci. 2017 Jul 15;105:82-90. doi: 10.1016/j.ejps.2017.04.016. Epub 2017 May 3. Eur J Pharm Sci. 2017. PMID: 28478135

5

NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats.

Becker R, Gass N, Kußmaul L, Schmid B, Scheuerer S, Schnell D, Dorner-Ciossek C, Weber-Fahr W, Sartorius A. Becker R, et al. Among authors: scheuerer s. Psychopharmacology (Berl). 2019 Dec;236(12):3451-3463. doi: 10.1007/s00213-019-05310-3. Epub 2019 Jul 2. Psychopharmacology (Berl). 2019. PMID: 31267156

6

Effect of clofibrate on the chiral disposition of ibuprofen in rats.

Scheuerer S, Williams KM, Brugger R, McLachlan AJ, Brune K, Day RO, Geisslinger G. Scheuerer S, et al. J Pharmacol Exp Ther. 1998 Mar;284(3):1132-8. J Pharmacol Exp Ther. 1998. PMID: 9495875

7

Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation.

Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M. Beiche F, et al. Among authors: scheuerer s. FEBS Lett. 1996 Jul 22;390(2):165-9. doi: 10.1016/0014-5793(96)00604-7. FEBS Lett. 1996. PMID: 8706851 Free article.

8

Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.

Kley JT, Mack J, Hamilton B, Scheuerer S, Redemann N. Kley JT, et al. Among authors: scheuerer s. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5924-7. doi: 10.1016/j.bmcl.2011.07.083. Epub 2011 Aug 9. Bioorg Med Chem Lett. 2011. PMID: 21873051

9

Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations.

Hanft G, Türck D, Scheuerer S, Sigmund R. Hanft G, et al. Among authors: scheuerer s. Inflamm Res. 2001 Mar;50 Suppl 1:S35-7. doi: 10.1007/PL00000219. Inflamm Res. 2001. PMID: 11339520 Clinical Trial.

10

Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.

Euller-Ziegler L, Vélicitat P, Bluhmki E, Türck D, Scheuerer S, Combe B. Euller-Ziegler L, et al. Among authors: scheuerer s. Inflamm Res. 2001 Mar;50 Suppl 1:S5-9. doi: 10.1007/PL00022377. Inflamm Res. 2001. PMID: 11339521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results